Home › Treatments › Hematology › Adakveo
Adakveo
Hematology
- Manufacturer: Novartis
- Salt Composition: crizanlizumab
- Pack Size: Single-dose vial
- Prescription Required
Introduction
Adakveo (crizanlizumab) is a medication used to prevent painful crises in patients with sickle cell disease aged 16 years and older.
It is the first targeted therapy approved for sickle cell disease.
Safety Advice
Pregnancy: Consult Doctor
Lungs: Consult Doctor
Breastfeeding: Consult Doctor
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.